Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
Clinical trial NCT04056299 · TERMINATED
Trial details
- NCT number
- NCT04056299
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2020-12-16
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.